Sangamo Therapeutics Announces Conference Call To Review SB-913 CHAMPIONS Study Data And Participation At Upcoming Investor Conferences
Sangamo also announced today that management will participate in the following healthcare investor conferences in September.
- 2018
Wells Fargo Healthcare Conference ,Boston, MA ,September 5-6, 2018
Sangamo's presentation is scheduled for
The
Bank of America Merrill Lynch Global Healthcare Conference 2018,London, UK ,September 11-14, 2018
Sangamo's presentation is scheduled for
Webcasting services are not provided at the
SB-913 Conference Call
Sangamo will host a conference call on
The conference call dial-in numbers are (877) 377-7553 for domestic callers and (678) 894-3968 for international callers. The conference ID number for the call is 8798741. For those unable to listen in at the designated time, a conference call replay will be available for one week following the conference call. The conference call replay numbers for domestic and international callers are (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 8798741.
About
View original content with multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-conference-call-to-review-sb-913-champions-study-data-and-participation-at-upcoming-investor-conferences-300704736.html
SOURCE
Sangamo Therapeutics, Inc., McDavid Stilwell, 510-970-6000, x219, mstilwell@sangamo.com; or Varant Shirvanian, 510-970-6000 x205, vshirvanian@sangamo.com